Technology

CARESYNTAX ANNOUNCES 2024 HIGHLIGHTS

Published

1 year ago

December 23, 2024

Company Celebrates Continued Worldwide Progress Toward Data-Driven Surgery

SAN FRANCISCO and BERLIN, Dec. 23, 2024 /PRNewswire/ — Caresyntax, the leading vendor of data-driven surgical intelligence solutions to make surgery safer and smarter, today announced its highlights and achievements of 2024. The company achieved top line 2024 organic revenue growth over 50%, with its technology and services platform used in over 4,000 ORs across the world. Due to increasing commercial velocity in the US and EU hospital markets, and expansion into new geographies and industry verticals, the company was recognized with multiple industry awards including selection to the Fierce 15 most innovative companies and the 2024 German AI prize. The company also completed a $180 million fundraise to fuel this explosive top and bottom-line growth. The company forecasts continued velocity into 2025 with focus on scale, and operational deployment, and worldwide expansion.

Continued growth in core business lines: Integrated OR and Connected Surgery
Building upon its established footprint in Europe, Caresyntax further cemented its position as the leader in surgical intelligence and OR-integration solutions with new business awards in France (Nantes, Lyon), Germany (Berlin, Hamburg), Spain (Tenerife), and Switzerland (Fribourg, Morges), alongside expansion within its existing network of hospital partners. In addition to commercial revenue, these commercial partnerships also expanded the Caresyntax portfolio to include software, services, and Internet of Things (IoT) functionalities.

In the Americas, Caresyntax continued the commercial rollout of its advanced OR Integration Connected Surgery offering, inking deals with two different large hospital systems in Florida, along with hospitals in Mexico (Mexico City, Oaxaca, Campeche), and Chile (Santiago). The market has shown great interest in Connected Surgery’s benefits: a lightweight footprint, vendor-neutrality, cost-effectiveness compared to traditional OR integration, and future-proof capability for continuous evolution and updates through a cloud-based architecture. In addition to new hospital placements, the company also focused on value delivery and expansion within its flagship customers in the US, signing expansion deals for its OR analytics, OR scheduling, Video-Based Assessment, OR workflow, and Clinical Value Assessment solutions with key customers including Universal Health Services (UHS), the OSF Healthcare, the Ascension Health Alliance, and the University of Iowa.

New CDaaS offering for medtech partners: rapid adoption and uptake from industry
Launched at the J.P. Morgan Healthcare Conference in January 2024, Caresyntax completed the development and deployment of the Clinical Data as a Service (CDaaS) portfolio for medtech partners. Building upon decades of thought leadership by the company’s Chief Medical Informatics Officer, Bruce Ramshaw, MD, the company integrated his team’s continuous quality improvement methodology, advanced systems science, and user-friendly dashboard analytics into the Caresyntax platform. The key differentiators of the Caresyntax data collection platform include flexibility (no strict protocols, IRB, or patient consent), data accuracy (data ingestion, curation, and cleansing), and speed (data for publication within months, compared to years.) Most importantly, CDaaS offerings can be tailored around existing clinical evidence strategy, wrapping around trial sites or collecting data from entirely different clinical sites.
In its first year on the market, the portfolio developed into a multi-million-dollar business with win rates well above traditional SaaS business models (Caresyntax win rate above 40%), tremendous market upside (7 new partnerships signed in Q3 and Q4), outstanding retention rates (3 existing customers inked expansion or renewal), and annual revenue growth projected above 100%. In 2024, CDaaS data was used for 10 abstracts or poster presentations, 2 society presentations, 2 published manuscripts, and 1 FDA indication expansion. Caresyntax has signed deals with medtech customers across all surgical specialties, with interest from the complete range of partner sizes, from early-stage startups to multinational strategic players.

Leveraging Strategic Collaborations and Key Partnerships
In addition to its direct-to-customer activities, Caresyntax also established key partnerships that provide accretive revenue and additional avenues for commercial success. The company expanded its partnership with D-Scope technologies to co-develop data analysis tools and advanced reporting capabilities for use in public, private, Veterans Administration, and Department of Defense Hospitals. The company also inked a partnership with surgical startup Qaelon to create a decentralized registry for real world data, with the aspirational goal to update the standard of care for surgical leak detection. And most recently, the company signed an initial deal with the American Hernia Society to create the backend infrastructure and frontend data visualization platform for all its members. These partnerships show promise as multiplier opportunities for expansion and cross-sell of core Caresyntax platform capabilities further downstream.

Product Innovation
In 2024, Caresyntax furthered its application of AI in the operating room to transform healthcare. By integrating AI at critical points in surgical workflows, Caresyntax helped customers enhance efficiency, reduce errors, and unlock valuable insights from previously unusable data sources.

To assist with OR scheduling and throughput, Caresyntax introduced its Block Marketplace module across 25 hospitals and 670 practices nationwide. Block Marketplace proactively identifies potential scheduling conflicts and resource availability issues, optimizes utilization, adapts to real-time demands, and serves as a marketplace for open surgery time, maximizing prime-time utilization of the operating room.

With the launch of Connected Surgery, Caresyntax introduced supervised machine learning algorithms to help surgical leaders with operational efficiency measures throughout the surgical suite: reducing turnover time, improving compliance with the surgical safety checklist, and identifying operational bottlenecks. Caresyntax also rolled out a new Turn-by-Turn Guidance module to help clinical teams navigate and prepare for different phases of surgery.

Core to all its product offerings are the diverse data flows coming out of the varied systems of the hospital. This year, the company launched several new capabilities to capture and curate diverse multimodal data, leveraging the functionality of Generative AI and Large Language Models (LLMs). With these evolving models, the company can make more use of complex and variable unstructured sources like surgical notes and medical records to inform better algorithms and products.

Significant Momentum and Focus on Data Streams in 2025
Carrying forward this significant momentum from 2024, the company is excited to continue its growth trajectory across the Americas, Europe, and the Middle East in 2025. In addition to its expanding list of clinical sites, the company is especially excited to harness the power of its growing database of data sourced directly from the OR environment. The Caresyntax platform captures unparalleled data from the surgical continuum, including pathway decisions, in-room video, surgical and endoscopic tower feeds, clinical and financial outcomes, supply chain and cost information, and pre- and post-operative patient information. As the company expands its footprint of OR Integration and medtech customers, those integrations contribute to create the most rich, differentiated dataset available from the surgical environment. Throughout 2025, the company plans to expend significant R&D capacity on its proprietary data analytics engine, to drive unique and novel insights for clinical, administrative, regulatory, and commercial partners downstream.

About Caresyntax
Caresyntax is on a mission to make surgery smarter and safer by converging AI-powered software, devices, and clinical services to help customers improve surgical outcomes. Our vendor neutral, enterprise-grade surgical intelligence platform delivers actionable insights to improve patient outcomes by using proprietary software and artificial intelligence (AI) to analyze large volumes of video, audio, images, device data, clinical and operational data in and around the OR. This real-world evidence can be used by the care team live, during a procedure, and accessed by those outside the operating room via the platform’s dedicated telehealth link. After a procedure, the Caresyntax platform provides insights that help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. Headquartered in San Francisco in the US and internationally in Berlin, Caresyntax software is used in more than 3,000 operating rooms worldwide and supports surgical teams in more than three million procedures per year. For more information, visit Caresyntax.com

Caresyntax Contact:
info@caresyntax.com

US Media Contact:
info@caresyntax.com

International Media Contact:
Gargee Kashyap
Senior Marketing Manager
Gargee.kashyap@caresyntax.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/caresyntax-announces-2024-highlights-302338460.html

SOURCE Caresyntax

Technology

Hyundai Motor Connects with Next Generation of Football Fans through ‘Hyundai NEXT Cup Tour’ on ‘Top Eleven’

Published

23 minutes ago

April 23, 2026

Hyundai Motor, together with Nordeus, launches the ‘Hyundai NEXT Cup Tour,’ an immersive in-game event on the popular mobile football management game ‘Top Eleven: Be a Football Manager’The campaign builds on Hyundai Motor’s 25+ year history in football, extending its presence beyond physical stadiums to connect with digital-native generations (Gen Z and Gen Alpha)The event integrates Hyundai Motor’s strategic vehicle models into a 10-nation virtual tour, reinterpreting their unique features as in-game football skillsThis collaboration marks Hyundai Motor’s expansion into the tactical football management genre, moving beyond traditional racing game partnerships

SEOUL, South Korea, April 22, 2026 /PRNewswire/ — Hyundai Motor Company today announced the launch of the ‘Hyundai NEXT Cup Tour,’ a new in-game event in ‘Top Eleven : Be a Football Manager‘, one of the world’s most popular mobile football management games.

Running from April 23–May 2, the event coincides with Top Eleven’s 16th Anniversary season, leveraging a period of peak player engagement. As football fandom continues to evolve, Hyundai Motor has been exploring new ways to connect with fans across different environments and moments — from shared live experiences to more personal, digital-first forms of engagement. Rather than simply branching into new genres, the initiative broadens the football experience beyond physical venues — creating a vibrant space for fans to connect with the sport anytime, anywhere.

“For more than 25 years, football has been a powerful platform for Hyundai to connect with people worldwide. With the ‘Hyundai NEXT Cup Tour’ in Top Eleven, we are opening a new chapter by translating the energy and strategy of the game into an interactive experience. This collaboration feels native to digital-first audiences and reflects how the next generation engages with the sport they love.” – Sungwon Jee, Executive Vice President and Global Chief Marketing Officer at Hyundai Motor Company

“Hyundai Motor has, for years, been at the intersection of football and some of the world’s most celebrated brands, so welcoming them to the Top Eleven touchline is an exciting milestone. As the game approaches its 16th anniversary of delighting football fans worldwide, bringing this event to life at such a thrilling moment for football, together with Hyundai Motor, reflects Top Eleven’s commitment to continuously finding new ways to deliver unique, evergreen football stories for fans.” – Marko Jevtic, Executive Vice President at Nordeus

What is the ‘Hyundai NEXT Cup Tour’?

‘Hyundai NEXT Cup Tour’ invites Top Eleven players to manage their club through a series of 10 sequential missions across the world. The virtual tour begins in Indonesia and travels through 10 of Hyundai Motor’s key global markets, culminating in the United States, mirroring the brand’s story of global growth. This structure allows the brand to deliver high-impact engagement that connects with the game’s core loop of strategy, progression and decision-making.

How Does the In-Game Integration Work?

Rather than a one-way advertising exposure, the event seamlessly integrates Hyundai Motor’s flagship vehicle models into the player’s strategic journey. Each of the 10 tour stops features a locally representative model, with the vehicle’s unique selling proposition reinterpreted as an in-game football activity.

For example, IONIQ 5’s ultra-fast charging is framed as keeping a team’s condition high during a packed schedule, while INSTER’s blend of speed and compactness positions it well for reacting at a moment’s notice with velocity and agility. Players who progress through the in-game missions can earn exclusive, limited-edition Hyundai-branded in-game items, including a team jersey and an emblem.

This initiative reflects Hyundai Motor’s commitment to evolving its brand experience for digital natives, carrying the energy, unity and inspiration of sport into the next generation of gaming experiences.

More information about Hyundai Motor and its products can be found at:
https://www.hyundai.com/worldwide/en/ or Newsroom: Media Hub by Hyundai

View original content to download multimedia:https://www.prnewswire.com/news-releases/hyundai-motor-connects-with-next-generation-of-football-fans-through-hyundai-next-cup-tour-on-top-eleven-302750066.html

SOURCE Hyundai Motor Company

Technology

SK hynix Announces 1Q26 Financial Results

Published

23 minutes ago

April 23, 2026

Reports revenues of 52.5763 trillion won, operating profit of 37.6103 trillion won, net profit of 40.3459 trillion wonRecord-high quarterly performance driven by increased sales of high value-added products from strong AI demandBy launching advanced products, the company will try to address growing market demand in the looming agentic AI eraCompany to secure both stable supply and robust financial conditions through investment aligned with demand

SEOUL, South Korea, April 22, 2026 /PRNewswire/ — SK hynix Inc. (or “the company”, www.skhynix.com) announced today that it has recorded 52.5763 trillion won in revenues, 37.6103 trillion won in operating profit (with an operating margin of 72%), and 40.3459 trillion won in net profit (with a net margin of 77%) in the first quarter.

Revenue surpassed 50 trillion won for the first time on a quarterly basis, while operating profit and operating margin reached record highs at 37.6 trillion won and 72%, respectively[1]. Operating profit has nearly doubled compared to the previous quarter, clearly demonstrating an improving profitability.

[1] 4Q2025 Revenue: 32.8267 trillion won / 4Q2025 Operating Profit: 19.1696 trillion won

SK hynix noted that despite the fact that first quarter is typically a seasonal downturn, strong demand persisted due to expanded investments in AI infrastructure. The company sustained its upward performance trend by increasing sales of high-value-added products, including HBM, high-capacity server DRAM modules, and eSSDs.

Building on this strong performance, the company’s cash and cash equivalents at the end of the first quarter increased by 19.4 trillion won from the previous quarter, reaching 54.3 trillion won. Meanwhile, interest bearing debt stood at 19.3 trillion won down 2.9 trillion won from the previous quarter, enabling the company to reach a net cash position of 35 trillion won.

The company analyzed that as AI evolves from large model training to the stage of agentic AI, which repeatedly performs real-time inference across various service environments, the foundation for memory demand is expanding across both DRAM and NAND flash.

SK hynix also predicted that the spread of memory efficiency technologies will enhance the economic viability of AI services, leading to an expansion of the overall service scale and further drive memory demand. Based on this, the company forecasted that favorable pricing conditions will continue for both DRAM and NAND flash.

To meet this demand, the company, plans to continue rolling out new products across both DRAM and NAND flash to address the diversifying memory demand.

Regarding HBM, the company will further strengthen its capabilities, encompassing performance, yield, quality, and supply stability. In DRAM, the company will fully ramp up the shipment of LPDDR6, which applied 1cnm process, or the sixth-generation of the 10-nanometer technology, for the world’s first time, and the 192GB SOCAMM2, which is based on the same process and began mass production this month.

For NAND flash, the company will flexibly address AI demand with CTF[2] based 321-layer QLC[3] cSSD ‘PQC21’, and eSSD lineup of high-performance TLC and high-capacity QLC. Especially, by leveraging synergies with Solidigm, which holds strengths in high-capacity QLC eSSDs, the company plans to strengthen its competitiveness in the AI data center and AI PC storage markets.

[2] Charge Trap Flash (CTF): Unlike floating gate, which stores electric charges in conductors, CTF stores electric charges in insulators, which eliminates interference between cells, improving read and write performance while reducing cell area per unit compared to floating gate technology.

[3] Quad-level cell (QLC): NAND flash is categorized as single-level cell (SLC), multi-level cell (MLC), triple-level cell (TLC), QLC, and penta-level cell (PLC) depending on how many data bits can be stored in one cell. As the amount of information storage increases, more data can be stored in the same volume.

Meanwhile, SK hynix emphasized that within the environment where customer demand exceeds supply capacity, securing stable supply capability to meet the structural demand growth of the AI era has emerged as a key competitive advantage.

Accordingly, the company explained that this year’s investment scale will increase significantly compared to the previous year, focusing on the ramp-up of M15X, infrastructure preparation on the Yongin cluster, and securing key equipment such as EUV.

The company highlighted that it will secure both stable supply and robust financial conditions through investment aligned with demand and will strategically expand production bases to proactively respond to long-term demand growth.

1Q26 Financial Results (K-IFRS)

*Unit: Billion KRW

1Q26

QoQ

YoY

4Q25

Change

1Q25

Change

Revenues

52,576.3

32,826.7

60 %

17,639.1

198 %

Operating Profit

37,610.3

19,169.6

96 %

7,440.5

405 %

Operating Margin

72 %

58 %

14%P

42 %

30%P

Net Income

40,345.9

15,246.0

165 %

8,108.2

398 %

※ Financial information of the earnings is based on K-IFRS

※ Please note that the financial results discussed herein are preliminary and speak only as of April 23, 2026. Readers should not assume that this information remains operative at a later time.

Disclaimer

This material has been prepared by the Company for informational purposes only, and the information contained herein has not undergone any separate, independent verification process. No representations or warranties are made regarding the fairness, accuracy, or completeness of the information contained in this material, and such information should not be relied upon. Neither the Company nor its employees bear any civil, criminal, or administrative liability for any damages arising from this material or from its use.

Review of the FY2026 Q1 financial results has not been finalized. Figures in this earnings release are subject to changes during the independent auditing process.

All financial information contained in this document is based on consolidated K-IFRS.

This material contains forward-looking statements which can be subject to certain risks and uncertainties that could cause actual results to differ materially.

This material does not constitute a solicitation for the acquisition or purchase of securities, and no part of this material should serve as the basis for any contract, agreement, or investment decision, nor should it be relied upon in connection therewith.

About SK hynix Inc.

SK hynix Inc., headquartered in Korea, is the world’s top tier semiconductor supplier offering Dynamic Random Access Memory chips (“DRAM”) and flash memory chips (“NAND flash”) for a wide range of distinguished customers globally. The Company’s shares are traded on the Korea Exchange, and the Global Depository shares are listed on the Luxembourg Stock Exchange. Further information about SK hynix is available at www.skhynix.com, news.skhynix.com.

View original content:https://www.prnewswire.com/news-releases/sk-hynix-announces-1q26-financial-results-302750959.html

SOURCE SK hynix Inc.

Technology

RhythMedix Launches Next-Generation RhythmStar® SL Cardiac Monitor

Published

1 hour ago

April 22, 2026

Advancing Remote Cardiac Monitoring with Faster Insights, Greater Comfort, and Seamless Connectivity

MOUNT LAUREL, N.J., April 22, 2026 /PRNewswire/ — RhythMedix, LLC (RhythMedix), a nationwide U.S.-based cardiac monitoring company, today announced the launch of its next-generation RhythmStar® SL cardiac monitoring wearable. The third-generation design significantly enhances the patient experience, improving comfort, wearability, and patient adherence. These advancements are enabled by a compact lead configuration, waterproof IPX-6 rating, and increased battery life.

RhythmStar continues to differentiate through its built-in cellular connectivity, enabling ECG data to be automatically transmitted to the cloud for seamless, prompt review across all monitoring modes – without requiring device return by mail for data processing.

When paired with the company’s proprietary Augmented Arrhythmia Intelligence™ (AAI), RhythmStar SL delivers precise arrhythmia detection by combining advanced algorithms with a multi-layered data review process.

“RhythmStar represents our commitment to delivering a better way to monitor, one that prioritizes both patient comfort and clinical performance,” said Brian Pike, CEO of RhythMedix. “By combining a more wearable design with seamless data transmission and expert review, we’re helping clinicians access the insights they need, when they need them.”

“RhythMedix is taking a truly visionary approach to cardiac monitoring by combining patient-friendly design with advanced technology and expert oversight, helping clinicians make more confident, timely decisions,” stated George Shaw, MD, Electrophysiologist at AHN Allegheny Health Network. “It’s a meaningful step forward in how we deliver and manage cardiac care.”

With over 2 million hearts monitored to date, RhythMedix continues to advance remote cardiac monitoring through technology designed to improve both patient adherence and clinical workflow. The company will be exhibiting at HRS 2026 (Booth #531), including in-booth discussions with leading electrophysiologists.

About RhythMedix

Founded in 2013 and headquartered in Mount Laurel, New Jersey, RhythMedix is a fully integrated cardiac monitoring company providing end-to-end device manufacturing, software development, and 24/7 U.S.-based monitoring services. With no third-party dependence, RhythMedix delivers a seamless and secure remote cardiac monitoring experience for clinics, health systems, and patients nationwide.

To learn more, visit rhythmedix.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/rhythmedix-launches-next-generation-rhythmstar-sl-cardiac-monitor-302750932.html

SOURCE RHYTHMEDIX